课题基金 / 基金详情

The role of TRPM8 in susceptibility to highly pathogenic avian influenza A/H5N1

The role of TRPM8 in susceptibility to highly pathogenic avian influenza A/H5N1
TRPM8在高致病性禽流感A/H5N1易感性中的作用
批准号:
MR/L008599/1
负责人:
Peter Horby
金额:
$35.55万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Peter Horby的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the last decade an animal influenza A virus has crossed the species barrier and caused an appreciable number of human cases on five occasions. Highly pathogenic avian influenza A(H5N1) has resulted in very rare episodes of limited person-to-person transmission but has not adapted to humans. Another avian influenza virus (H7N7) caused a large number of, mostly mild, human infections in the Netherlands in 2003 and also demonstrated some ability for limited person-to-person transmission, but was successfully controlled by extensive culling of poultry flocks. The swine H1N1 influenza virus that emerged in 2009 successfully adapted to humans, caused a pandemic, and is now firmly established as a human influenza virus. Another swine-origin virus (H3N2v) has been transmitted occasionally from pigs to humans in the U.S. since 2011 but has not managed to switch hosts and become established in the human population. The ongoing avian influenza A(H7N9) outbreak that was first detected in China in February 2013 has caused more than 130 human cases at the time of writing, and shows some evidence of adaptation to humans. A central question that arises when an animal influenza virus crosses the species barrier and infects humans is the probability that the virus will adapt to humans and cause a pandemic. Despite much research, the barriers that must be overcome for animal influenza viruses to stably adapt to humans are still not fully understood. Assessing the public health threat of H5N1 and other animal influenza viruses requires a fuller understanding of what currently constrains the ability of animal influenza viruses to infect humans and to transmit between humans. The characteristics of influenza viruses that are associated with adaptation to humans have been studied in detail. However, the human-host characteristics are much less well studied. Around one third of all human H5N1 cases have occurred in clusters, and 50 of the 54 H5N1 clusters reported as of March 2009 were comprised entirely of blood relatives. We and other authors have concluded that this familial clustering and other aspects of the epidemiology of H5N1 suggest a role for host genetic factors.To test our hypothesis that host genetic factors may play an important role in restricting susceptibility to H5N1, we conducted a study to look for human genetic factors that might be associated with an increased risk of getting H5N1 infection. We studied 65 people with H5N1 infection (cases) and 2,910 people without H5N1 infection (controls) and found a variant in one particular gene (TRPM8) that was more common in cases compared to controls. We went on to study the effect of this gene on H5N1 infection in cells in the laboratory and in mice. We found that this gene did indeed affect the ability of the H5N1 virus to replicate in cells and to cause disease in mice. The aim of this new research is to futher determine and characterize the role of the TRPM8 gene in susceptibility to infection with H5N1. We will do this by (1) gathering samples and analysing the genetic code from human H5N1 cases in Indonesia to test if the genetic variant is also present this independent set of samples, (2) fully sequencing the whole TRPM8 gene in cases and controls to identify precisely which genetic variations may be responsible, (3) exploring how different influenza viruses bind to the protein produced by the TRPM8 gene, and (4) further assessing the role of TRMP8 in H5N1 infection in mice.This research is important since the results will provide new information on the adaptations necessary for animal influenza viruses to succesfully infect humans and may also provide a new target for drugs to prevent or treat influenza infections.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
COVID-19: multi-arm, multi stage adaptive clinical trial (CoV-MAMS)
  • 批准号:
    MC_PC_19056
  • 项目类别:
    Intramural
  • 资助金额:
    $268.35万
  • 财政年份:
    2020
  • 负责人:
    Peter Horby
  • 依托单位:
国内基金
海外基金
宫颈上皮细胞TRPM8介导CD11chigh巨噬细胞扩增在自发性早产宫颈过早成熟的作用机制
活化FFAR4构建TRPM8通道低活性脱敏态对慢阻肺气道黏液冷刺激性高分泌的遏制效应研究
  • 批准号:
    82300054
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王静
  • 依托单位:
电针通过PKC信号通路调控TRPM8治疗干眼的机制研究
  • 批准号:
    22ZR1458500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
    杨延婷
  • 依托单位:
常温携氧机械灌注通过TRPM8/ACSL1调控线粒体功能改善脂肪供肝质量的机制研究
  • 批准号:
    82200734
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    范林
  • 依托单位: